LeadingBiotech: Boston CEO is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Jodie Morrison
Chief Executive Officer at Cadent Therapeutics


Jodie Morrison is the Chief Executive Officer of Cadent Therapeutics and is a member of Cadent’s Board of Directors. Ms. Morrison most recently served as interim Chief Executive Officer at Keryx Biopharmaceuticals, Inc.  Previously she served as President and Chief Executive Officer of Tokai Pharmaceuticals, Inc. Prior to being appointed President and Chief Executive Officer at Tokai, Ms. Morrison held other senior positions with the company, including Chief Operating Officer, Head of Clinical Affairs and Program Operations, and Vice President of Clinical Affairs and Program Operations. Prior to joining Tokai, Ms. Morrison held roles in clinical operations and medical affairs at Dyax Corporation, Curis, Inc., and Diacrin, Inc. Ms. Morrison currently sits on the Board of Directors for Akebia Therapeutics (AKBA) and Aileron Therapeutics (ALRN).

Ms. Morrison received a B.A. in neuroscience from Mount Holyoke College, her clinical research certification from Boston University School of Medicine, and her business training through the Greater Boston Executive Program at the MIT Sloan School of Management.

Jodie Morrison's Network

Agenda Sessions

  • Accessing Diverse Leadership in Life Sciences

    , 8:15am

Speakers at this event